Edwards Lifesciences Corporation (ETR:EWL)
Germany flag Germany · Delayed Price · Currency is EUR
66.08
-0.36 (-0.54%)
At close: May 9, 2025, 5:30 PM CET

Revenue by Product

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Transcatheter Aortic Valve Replacement
4.14B
Log In
Log In
Log In
Log In
Transcatheter Aortic Valve Replacement Growth
5.20%
Log In
Log In
Log In
Log In
Surgical Structural Heart
999.60M
Log In
Log In
Log In
Log In
Surgical Structural Heart Growth
1.64%
Log In
Log In
Log In
Log In
Critical Care
-
Log In
Log In
Log In
Log In
Critical Care Growth
-
Log In
Log In
Log In
Log In
Transcatheter Mitral and Tricuspid Therapies
394.40M
Log In
Log In
Log In
Log In
Transcatheter Mitral and Tricuspid Therapies Growth
72.30%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
3.27B
Log In
Log In
Log In
Log In
United States Growth
8.23%
Log In
Log In
Log In
Log In
Europe
1.34B
Log In
Log In
Log In
Log In
Europe Growth
10.19%
Log In
Log In
Log In
Log In
Japan
336.50M
Log In
Log In
Log In
Log In
Japan Growth
-3.94%
Log In
Log In
Log In
Log In
Rest of World
588.20M
Log In
Log In
Log In
Log In
Rest of World Growth
8.16%
Log In
Log In
Log In
Log In